AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.700

+0.0253.70%

Volume:679.71K

Turnover:472.64K

Market Cap:294.65M

PE:-90.69

High:0.705

Open:0.690

Low:0.685

Close:0.675

52wk High:0.790

52wk Low:0.082

Shares:420.93M

Float Shares:347.84M

Volume Ratio:0.87

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.024

ROE:-14.47%

ROA:-7.24%

PB:13.72

PE(LYR):-29.23

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

40

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.7,"timestamp":1780035120000,"preClose":0.675,"halted":0,"volume":679712,"delay":0,"changeRate":0.0370370370370369,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":420928435,"eps":-0.007719,"marketStatus":"Not Yet Opened","change":0.025,"latestTime":"05-29 16:12:00 AEST","open":0.69,"high":0.705,"low":0.685,"amount":472643,"amplitude":0.02963,"askPrice":0.71,"askSize":5300,"bidPrice":0.695,"bidSize":1582,"shortable":3,"etf":0,"ttmEps":-0.007719,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1780272000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.675,"openAndCloseTimeList":[[1780012800000,1780034400000]],"volumeRatio":0.8696735831117145,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SPL.AU","preClose":0.675,"auctionPrice":0.7,"auctionVolume":166421,"auction":3,"marketStatus":"盘后竞价","timestamp":1780035000058}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-7.24%","roe":"-14.47%","lyrEps":-0.023946,"volumeRatio":0.8696735831117145,"shares":420928435,"dividePrice":0,"high":0.705,"amplitude":0.02963,"preClose":0.675,"low":0.685,"week52Low":0.082,"pbRate":"13.72","psRate":"20.21","week52High":0.79,"institutionHeld":0,"latestPrice":0.7,"committee":-0.54025,"eps":-0.007719,"divideRate":0,"volume":679712,"delay":0,"ttmEps":-0.007719,"open":0.69,"prevYearClose":0.36,"prevWeekClose":0.62,"prevMonthClose":0.73,"prevQuarterClose":0.47,"fiveDayClose":0.62,"twentyDayClose":0.71,"sixtyDayClose":0.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":40,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":0.129},{"period":"1month","weight":-0.0278},{"period":"3month","weight":0.5217},{"period":"6month","weight":0.7284},{"period":"1year","weight":6.8652},{"period":"ytd","weight":0.9444}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":0.0095},{"period":"3month","weight":-0.0414},{"period":"6month","weight":0.0115},{"period":"1year","weight":0.0842},{"period":"ytd","weight":-0.0073}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.018875},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.019471},{"month":3,"riseRate":0.384615,"avgChangeRate":0.025687},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.017764},{"month":5,"riseRate":0.36,"avgChangeRate":-0.041001},{"month":6,"riseRate":0.56,"avgChangeRate":0.039433},{"month":7,"riseRate":0.44,"avgChangeRate":0.004085},{"month":8,"riseRate":0.68,"avgChangeRate":0.099337},{"month":9,"riseRate":0.5,"avgChangeRate":0.017446},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016585},{"month":11,"riseRate":0.5,"avgChangeRate":0.028409},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.005804}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}